Driehaus Capital Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,020,098
Closed -$4.83M 425
2022
Q3
$4.83M Sell
1,020,098
-26,131
-2% -$131K 0.07% 274
2022
Q2
$5.06M Sell
1,046,229
-6,964
-0.7% -$42.3K 0.08% 271
2022
Q1
$6.7M Sell
1,053,193
-20,227
-2% -$109K 0.08% 276
2021
Q4
$6.67M Sell
1,073,420
-49,986
-4% -$391K 0.07% 277
2021
Q3
$9.72M Buy
+1,123,406
New +$9.17M 0.12% 240

Other funds holding THRN

Driehaus Capital Management's THRN Position: Q4 2022 in Review

Driehaus Capital Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2022, closing a stake of 1,020,098 shares — an estimated $4.83M sold.

Driehaus Capital Management first reported a position in THRN in Q3 2021 and held it in 5 quarters. The position peaked at $9.72M in Q3 2021. 45 funds tracked by Wall St. Rank hold THRN as of Q4 2022.

  • Driehaus Capital Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 1,020,098 Thorne Healthtech, Inc. Common Stock shares in Q4 2022, an estimated $4.83M.
  • Driehaus Capital Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Driehaus Capital Management's Thorne Healthtech, Inc. Common Stock position peaked at $9.72M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2022.

Based on Driehaus Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.